Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Septerna, Inc. Common Stock (SEPN) Insider Trading Activity
Healthcare • Biotechnology • 68 employees
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.
Total Value
$86,760,000.00
Total Shares
4,820,000
Average Trade Value
$21,690,000.00
Most Active Insider
Ra Capital Management, L.P.
Total Activity: $75,060,000
Largest Single Transaction
$68,911,200
by Ra Capital Management, L.P. on Oct 28, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Oct 28, 2024 | 3,828,400 | $68,911,200 | 5,523,915 (+69.3%) | Purchase | ||
| Oct 28, 2024 | 279,500 | $5,031,000 | 3,152,456 (+8.9%) | Purchase | ||
| Oct 28, 2024 | 341,600 | $6,148,800 | 1,471,943 (+23.2%) | Purchase | ||
| Oct 28, 2024 | 370,500 | $6,669,000 | 6,215,591 (+6.0%) | Purchase |